Oncology Competitive Intelligence Leaders
Solid Tumor Reports
ONCrg’s continually evolving products create digestible therapeutic landscapes in solid tumor indications. Comprehensive Pipeline Strategies include visual treatment and develop- ment algorithms by tumor subtype, cancer stage, and line of therapy. Detailed descriptions of novel and existing agents undergoing development complement these landscapes. Coverage includes trending therapeutic classes such as immunotherapies.
Our competitive intelligence in immuno-oncology fills a critical need for our clients. Subscribers receive ONCrg expert analysis and insights on collaboration agreements, research, and clinical trials for early and late stage products or technologies that are not clearly being developed in a specific cancer type that could lead to rapid approval and change treatment paradigms.
Hematologic Malignancy Reports
ONCrg’s suite of integrated, evergreen resources keep pace with the rapid shifts in hema- tology/oncology landscapes. Our monthly updates and innovative conference coverage complement in depth pipeline reports designed to provide either a quick visual summary or highly granular analysis with focus on key emerging drug classes including immunotherapies and epigenetic modifers.